Results 101 to 110 of about 52,437 (276)
Abstract High‐risk neuroblastomas exhibit a high degree of intratumoral heterogeneity. Single‐cell RNA sequencing has greatly improved our understanding of these tumors, but the method lacks cellular tissue context and spatial information about local signaling dynamics.
Joachim T Siaw+10 more
wiley +1 more source
Primary Pleomorphic Leiomyosarcoma of Male Breast
We describe the first case of primary pleomorphic leiomyosarcoma of breast in a 50 year old male. Initial biopsy was suggestive of malignant fibrous histiocytoma.
Muhammad Mumtaz Khan+4 more
doaj
Leiomyosarcoma of the Stomach: Case Reports [PDF]
Paul L. Shallenberger, John H. Doane
openalex +1 more source
ABSTRACT Background Bone sarcomas other than osteosarcoma, chondrosarcoma, and Ewing sarcoma represent a challenge in care because they are uncommon, especially in children, adolescents, and young adults (AYA). Methods We conducted a retrospective review of patients aged 0–25 years treated for non‐osteosarcoma, non‐chondrosarcoma, non‐Ewing (and ...
Rafael Moisan+16 more
wiley +1 more source
PI3K/AKT/mTOR inhibition in combination with doxorubicin is an effective therapy for leiomyosarcoma
BackgroundLeiomyosarcoma (LMS) is a common type of soft tissue sarcoma that responds poorly to standard chemotherapy. Thus the goal of this study was to identify novel selective therapies that may be effective in leiomyosarcoma by screening cell lines ...
Y. Babichev+11 more
semanticscholar +1 more source
ABSTRACT We present a case of a 39‐year‐old woman initially diagnosed with Merkel cell carcinoma (MCC), a highly aggressive neuroendocrine carcinoma, due to the presence of cytokeratin and neuroendocrine marker expression. The tumor was dermal based, showing small round blue cells with fine chromatin, scant cytoplasm, and scattered mitotic figures ...
Simon Moubarak+5 more
wiley +1 more source
Exposure Data of Cosmetic Products for Patients Undergoing Cancer Treatment
ABSTRACT Background Dermo‐cosmetics play a major role in the management of cutaneous side effects due to cancer treatments. Before marketing cosmetic products, a safety assessment using realistic exposure data must be performed. However, limited data are available for patients undergoing cancer treatments.
Pauline Roch‐Simon+4 more
wiley +1 more source
Comprehensive management of vulvovaginal cancers
Abstract Vulvar and vaginal cancers represent rare malignancies, with an incidence of 2.7 per 100,000 women for vulvar cancer, predominantly affecting women older than 60 years, although rising rates are observed in younger demographics. Approximately 90% of vulvar cancers are squamous cell carcinoma and frequently are associated with human ...
Angélica Nogueira‐Rodrigues+5 more
wiley +1 more source
Leiomyosarcoma of the Intestine Presenting with Melaena [PDF]
L A Price, R D Tonkin
openalex +1 more source